AI healthcare stock poised for 36,996% growth?

The former FDA commissioner said, it "holds enormous promise for the future of medicine." ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ Unsubscribe Dear Fellow Investor, The former FDA commissioner said, it "holds enormous promise for the future of medicine." The Institute of Cancer Research, says it will have a "transformative effect on drug discovery." It's a breakthrough we call the "AI Healthcare Genesis"... and it's setting the stage for an unprecedented era in medicine. In fact, we expect it to grow by as much as 36,996% in as little as 6 years. That's right, 36,996%. And the best part? The stock is trading at just $25 a share. That means it's not too late to get in early... before everyone else finds out. Get the stock ticker here >>> All the best, Simmy Adelman, Publisher Behind the Markets Thank you for subscribing to DividendStocks.com's daily newsletter for dividend and income investors that covers ex-dividend stocks, new dividend declarations, dividend stock ideas, and the latest market news.   This message is a paid advertisement sent on behalf of Behind the Markets, a third-party advertiser of DividendStocks.com and MarketBeat.   If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.   If you no longer wish to receive email from DividendStocks.com, you can unsubscribe.   © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.   Today's Bonus Content: Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS